Whalegun
Home

Elliot Norry, Chief Medical Officer: Adaptimmune Therapeutics ADAPY Sell · Filed 24/01/17

Trade details

Type
Insider sale
Amount
$8,687.89
Shares · price
12,967 sh · $0.67 a share
Held after
19,257 sh
Stock
Adaptimmune Therapeutics ADAPY
Person
Elliot NorryChief Medical Officer
Trade date
24/01/17
Filed
24/01/17
Days to filing
0 days

Sold 40.2% of holdings

Share of holding sold
40.2%

Adaptimmune Therapeutics trades, last 26 weeks

What else happened in Adaptimmune Therapeutics around then

Filed or reported within 30 days of the trade day · 23/12/18~24/02/16

Elliot Norry's recent trades

  • Elliot Norry

    SellAdaptimmune Therapeutics

    $3,239

    Filed 25/01/17

  • Elliot Norry

    Planned saleAdaptimmune Therapeutics

    $3,243

    Filed 25/01/17

  • Elliot Norry

    SellAdaptimmune Therapeutics

    $5,588

    Filed 25/01/15

  • Elliot Norry

    SellAdaptimmune Therapeutics

    $4,793

    Filed 25/01/15

  • Elliot Norry

    SellAdaptimmune Therapeutics

    $2,518

    Filed 25/01/15

Elliot Norry, Chief Officer — sold $8,688 of Adaptimmune Therapeutics ADAPY · 40.2% of holdings | Whalegun